ASCENDIS PHARMA A/S shareholders Q3 2023

ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 164 filers reported holding ASCENDIS PHARMA A/S in Q3 2023. The put-call ratio across all filers is 1.12 and the average weighting 0.6%.

ASCENDIS PHARMA A/S shareholders Q3 2023
NameSharesValueWeighting ↓
VOLORIDGE INVESTMENT MANAGEMENT, LLC 19,908$1,864,1850.01%
SkyView Investment Advisors, LLC 228$210.01%
CAPTRUST FINANCIAL ADVISORS 24,029$2,250,0760.01%
GOLDMAN SACHS GROUP INC 409,973$38,389,8720.01%
OPPENHEIMER ASSET MANAGEMENT INC. 5,284$494,7940.01%
PEAK6 Investments LLC 15,500$1,451,4200.01%
Baillie Gifford 86,321$8,083,0980.01%
DekaBank Deutsche Girozentrale 30,000$2,8430.01%
Private Ocean, LLC 481$45,0410.01%
Handelsbanken Fonder AB 11,367$1,0640.01%
MACROVIEW INVESTMENT MANAGEMENT LLC 46$4,3080.01%
NOMURA ASSET MANAGEMENT CO LTD 12,668$1,186,2320.01%
J.P. Morgan Private Wealth Advisors LLC 19,325$1,809,5930.01%
Clearstead Advisors, LLC 1,690$158,2520.01%
Bank of New York Mellon Corp 232,762$21,795,7980.01%
CITIGROUP INC 51,600$4,831,8240.00%
Mirae Asset Global Investments Co., Ltd. 13,803$1,292,5120.00%
TUDOR INVESTMENT CORP ET AL 3,413$319,5930.00%
Raymond James Financial Services Advisors, Inc. 14,990$1,403,6640.00%
Lindbrook Capital, LLC 283$26,5000.00%
External links

This page lists ASCENDIS PHARMA A/S's shareholders in Q3 2023. To view ASCENDIS PHARMA A/S's shareholder history, click here.